Tengjun Biotechnology (CHGH) Return on Equity ROE from the second quarter 2023 to second quarter 2022 and annually, average high and low, overall ranking from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket
 


Tengjun Biotechnology Corp   (CHGH)

Tengjun Biotechnology 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Tengjun Biotechnology in the second quarter 2023?
Tengjun Biotechnology Corp achieved a return on average equity (ROE) of 53.25 % in its second quarter 2023, which is below Tengjun Biotechnology 's average return on equity, which stands at 228.86%.

ROE decreased relative to the period ending , due to the decline in net income.

Within the Nonalcoholic Beverages industry Tengjun Biotechnology Corp achieved the highest return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2023 from 63 to 182.

What is ROE?




Return On Equity (Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Equity Change 653.85 % - - - -
Y / Y Net Income Change - -31.78 % - - -
Net Income (TTM) in Millions 7 12 12 8 4
Return On Equity (TTM) 53.25 % 115.7 % 208.85 % 537.63 % -
CHGH's Total Ranking # 182 # 63 # 39 # 16 # 0
Equity (TTM) in Millions 15 16 15 8 2
Seq. Equity Change -3.19 % 5.32 % 87.31 % 294.75 % -
Seq. Net Income Change - -89.3 % 1 % -12.56 % 622 %

Return On Equity Company Ranking
Within: No.
Industry # 1
Sector # 9
Overall # 182

Return On Equity Statistics
High Average Low
537.63 %
228.86 %
53.25 %
(Sep 30 2022)   (Jun 30 2023)





CHGH Annual Return On Equity (Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
Total Equity in Millions 15 -2 0 0 0
Y / Y Equity Change - - - - -
Net Income in Millions 12 -1 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity 79.96 % - - - -





Annual Roe Comment
In 2022 ROE fell to 79.96 %, despite net income growth.


More Return On Equity Ratios
Nonalcoholic Beverages Industry Roe Trends and Statistics
Consumer Non Cyclical Sector Return On Equity Statistics
CHGH's' Return on Equity at Yahoo Finance
CHGH's Roe Ratio versus Nonalcoholic Beverages Industry, Consumer Non Cyclical Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CHGH's Competitors
Subscribers only: Roe for Tengjun Biotechnology 's Suppliers
Subscribers only: Return On Equity for CHGH's Customers




Companies with similar Return On Equity at Jun 30 2023, within Consumer Non Cyclical Sector ROE
Chase Packaging Corporation  137.38 %
Lamb Weston Holdings Inc   134.67 %
The Davey Tree Expert Company  111.09 %
Bloomia Holdings inc   88.00 %
Medifast Inc   80.31 %
Cal maine Foods Inc   53.55 %
Tengjun Biotechnology Corp   53.25 %
Hershey Co  52.28 %
National Beverage Corp   47.05 %
Mama s Creations Inc   46.19 %
Pepsico Inc   44.67 %
Axil Brands Inc   42.48 %
Tingo Group Inc   42.31 %
Coca cola Consolidated Inc   40.24 %
Coca Cola Co  40.17 %
Diageo Plc  38.25 %
The Clorox Company  36.08 %
Cf Industries Holdings inc   35.53 %
Procter and Gamble Co  32.10 %
E l f Beauty Inc   25.78 %
S and w Seed Co  24.75 %
Brown forman Corporation  24.71 %
General Mills Inc   24.63 %
The Campbells Company  24.42 %
Interparfums Inc   22.85 %
Sanfilippo John B and Son Inc  22.20 %
Chs Inc   21.15 %
Bunge Global Sa  19.76 %
Monster Beverage Corp  19.75 %
Darling Ingredients Inc   19.74 %


Date modified: 2026-09-08T15:11:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.